Acquiring Company
Eli Lilly and Company
Acquired Company
Orna Therapeutics
Description
Eli Lilly has announced four acquisitions in Q1 2026, including Orna Therapeutics and others focusing on innovative therapies. This acquisition spree is driven by strong revenue performance from its existing drug franchises. Analysts expect a surge in biotech deals following recent regulatory changes.
Quick answer
Eli Lilly and Company is acquiring Orna Therapeutics, announced July 9, 2026. Eli Lilly and Company is based in Indianapolis, Indiana, United States.
- How much did Eli Lilly and Company pay for Orna Therapeutics?
- The deal value was not disclosed.
- What does Eli Lilly and Company do?
- Lilly is a medicine company turning science into healing to make life better for people around the world.
- Where are Eli Lilly and Company and Orna Therapeutics based?
- Eli Lilly and Company is based in Indianapolis, Indiana, United States. Orna Therapeutics is based in Cambridge, Massachusetts, United States.
- Who are the decision-makers at Eli Lilly and Company?
- Fundz holds 5 contacts at Eli Lilly and Company. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Jazz Pharmaceuticals acquires Actio Biosciences (August 10, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
- Bora Pharmaceuticals acquires MacroGenics' operations (July 2, 2026)
Who to call at Eli Lilly and Company, and when
When Eli Lilly and Company changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eli Lilly and Company raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eli Lilly and Company, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eli Lilly and Company. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eli Lilly and Company makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Orna Therapeutics?
Orna Therapeutics was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on July 9, 2026. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire Orna Therapeutics?
Eli Lilly and Company's acquisition of Orna Therapeutics was reported on July 9, 2026. Eli Lilly has announced four acquisitions in Q1 2026, including Orna Therapeutics and others focusing on innovative therapies. This acquisition spree is driven by strong revenue performance from its existing drug franchises. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Orna Therapeutics do?
Orna Therapeutics was founded on groundbreaking research by Alex Wesselhoeft, Ph.D., and Daniel G. Anderson, Ph.D., from MIT and built by MPM Capital and BioImpact Capital, an affiliate of MPM. It is privately held, operating in Biotechnology, and is based in Cambridge.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.